Health Canada approves two AstraZeneca COVID-19 vaccines
Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
Members
Immunimed Inc.
ImmuniMed Inc. is an innovative, clinical-stage, Research & Development Biopharmaceutical Company. ImmuniMed Inc. develops oral antibody therapy using passive vaccination to treat and prevent gastro-enteric infections. Their technology is designed to utilize chicken eggs as bioreactors to manufacture specific polyclonal antibodies – a new class of biopharmaceuticals.
Contact Info
6-62 Scurfield Blvd. Winnipeg R3Y 1M5 MB CanadaP: 1 204 487 0974
E: dr.pmaiti@neutratechglobal.com
W: immunimed.com
member